Literature DB >> 34634490

Each phospholipase A2 type exhibits distinct selectivity toward sn-1 ester, alkyl ether, and vinyl ether phospholipids.

Daiki Hayashi1, Varnavas D Mouchlis1, Edward A Dennis2.   

Abstract

Glycerophospholipids are major components of cell membranes and have enormous variation in the composition of fatty acyl chains esterified on the sn-1 and sn-2 position as well as the polar head groups on the sn-3 position of the glycerol backbone. Phospholipase A2 (PLA2) enzymes constitute a superfamily of enzymes which play a critical role in metabolism and signal transduction by hydrolyzing the sn-2 acyl chains of glycerophospholipids. In human cell membranes, in addition to the conventional diester phospholipids, a significant amount is the sn-1 ether-linked phospholipids which play a critical role in numerous biological activities. However, precisely how PLA2s distinguish the sn-1 acyl chain linkage is not understood. In the present study, we expanded the technique of lipidomics to determine the unique in vitro specificity of three major human PLA2s, including Group IVA cytosolic cPLA2, Group VIA calcium-independent iPLA2, and Group V secreted sPLA2 toward the linkage at the sn-1 position. Interestingly, cPLA2 prefers sn-1 vinyl ether phospholipids known as plasmalogens over conventional ester phospholipids and the sn-1 alkyl ether phospholipids. iPLA2 showed similar activity toward vinyl ether and ester phospholipids at the sn-1 position. Surprisingly, sPLA2 preferred ester phospholipids over alkyl and vinyl ether phospholipids. By taking advantage of molecular dynamics simulations, we found that Trp30 in the sPLA2 active site dominates its specificity for diester phospholipids.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ether phospholipids; Lipidomics; Molecular dynamics simulation; Phospholipase A(2); Plasmalogens

Mesh:

Substances:

Year:  2021        PMID: 34634490      PMCID: PMC9188868          DOI: 10.1016/j.bbalip.2021.159067

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   5.228


  41 in total

Review 1.  Functions of plasmalogen lipids in health and disease.

Authors:  Nancy E Braverman; Ann B Moser
Journal:  Biochim Biophys Acta       Date:  2012-05-22

2.  Cytosolic group IVA and calcium-independent group VIA phospholipase A2s act on distinct phospholipid pools in zymosan-stimulated mouse peritoneal macrophages.

Authors:  Luis Gil-de-Gómez; Alma M Astudillo; Carlos Guijas; Victoria Magrioti; George Kokotos; María A Balboa; Jesús Balsinde
Journal:  J Immunol       Date:  2013-12-13       Impact factor: 5.422

Review 3.  Mechanisms of action of docosahexaenoic acid in the nervous system.

Authors:  N Salem; B Litman; H Y Kim; K Gawrisch
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

4.  Roles of catalytic domain residues in interfacial binding and activation of group IV cytosolic phospholipase A2.

Authors:  Sudipto Das; Wonhwa Cho
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

5.  Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum.

Authors:  Andre Teigler; Dorde Komljenovic; Andreas Draguhn; Karin Gorgas; Wilhelm W Just
Journal:  Hum Mol Genet       Date:  2009-03-08       Impact factor: 6.150

6.  High plasmalogen and arachidonic acid content of canine myocardial sarcolemma: a fast atom bombardment mass spectroscopic and gas chromatography-mass spectroscopic characterization.

Authors:  R W Gross
Journal:  Biochemistry       Date:  1984-01-03       Impact factor: 3.162

7.  CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.

Authors:  K Vanommeslaeghe; E Hatcher; C Acharya; S Kundu; S Zhong; J Shim; E Darian; O Guvench; P Lopes; I Vorobyov; A D Mackerell
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

8.  Neuronal Orphan G-Protein Coupled Receptor Proteins Mediate Plasmalogens-Induced Activation of ERK and Akt Signaling.

Authors:  Md Shamim Hossain; Kurumi Mineno; Toshihiko Katafuchi
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

9.  CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field.

Authors:  Jumin Lee; Xi Cheng; Jason M Swails; Min Sun Yeom; Peter K Eastman; Justin A Lemkul; Shuai Wei; Joshua Buckner; Jong Cheol Jeong; Yifei Qi; Sunhwan Jo; Vijay S Pande; David A Case; Charles L Brooks; Alexander D MacKerell; Jeffery B Klauda; Wonpil Im
Journal:  J Chem Theory Comput       Date:  2015-12-03       Impact factor: 6.006

10.  Omega-3 versus Omega-6 fatty acid availability is controlled by hydrophobic site geometries of phospholipase A2s.

Authors:  Daiki Hayashi; Varnavas D Mouchlis; Edward A Dennis
Journal:  J Lipid Res       Date:  2021-08-30       Impact factor: 5.922

View more
  4 in total

1.  Antioxidant Role and Cardiolipin Remodeling by Redox-Activated Mitochondrial Ca2+-Independent Phospholipase A2γ in the Brain.

Authors:  Pavla Průchová; Klára Gotvaldová; Katarína Smolková; Lukáš Alán; Blanka Holendová; Jan Tauber; Alexander Galkin; Petr Ježek; Martin Jabůrek
Journal:  Antioxidants (Basel)       Date:  2022-01-20

Review 2.  Functions and mechanisms of cytosolic phospholipase A2 in central nervous system trauma.

Authors:  Hao-Jie Zhang; Yi-Tuo Chen; Xin-Li Hu; Wan-Ta Cai; Xiang-Yang Wang; Wen-Fei Ni; Kai-Liang Zhou
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

Review 3.  Regulation of plasmalogen metabolism and traffic in mammals: The fog begins to lift.

Authors:  Fabian Dorninger; Ernst R Werner; Johannes Berger; Katrin Watschinger
Journal:  Front Cell Dev Biol       Date:  2022-08-31

4.  The Phospholipid Molecular Species Profile of Apostichopus japonicus Tissues Modifies through Exposure to n-3 Polyunsaturated Fatty Acid-Deficient Diet.

Authors:  Ekaterina V Ermolenko; Tatyana V Sikorskaya; Valeria P Grigorchuk
Journal:  Mar Drugs       Date:  2022-09-15       Impact factor: 6.085

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.